{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:39:14Z","timestamp":1783186754180,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072194"],"award-info":[{"award-number":["82072194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.heliyon.2023.e13479","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:58:03Z","timestamp":1675375083000},"page":"e13479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Siming","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjuan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-4045","authenticated-orcid":false,"given":"Panfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e13479_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.heliyon.2023.e13479_bib3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41416-020-01031-z","article-title":"Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration","volume":"123","author":"Di Credico","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2023.e13479_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10555-017-9689-6","article-title":"Tobacco-related carcinogenesis in head and neck cancer","volume":"36","author":"Jethwa","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.heliyon.2023.e13479_bib5","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00784-020-03541-9","article-title":"Oral submucous fibrosis transforming into squamous cell carcinoma: a prospective study over 31 years in mainland China","volume":"25","author":"Jian","year":"2021","journal-title":"Clin. Oral Invest."},{"key":"10.1016\/j.heliyon.2023.e13479_bib6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/ijc.28643","article-title":"Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control","volume":"135","author":"Guha","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2023.e13479_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.28643","article-title":"Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control","author":"Guha","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2023.e13479_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib9","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/S1470-2045(17)30252-8","article-title":"The future of personalised radiotherapy for head and neck cancer","volume":"18","author":"Caudell","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/PRS.0000000000007977","article-title":"The profunda artery perforator flap: a versatile option for head and neck reconstruction","volume":"147","author":"Largo","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.heliyon.2023.e13479_bib11","article-title":"Multipaddled anterolateral thigh chimeric flap for reconstruction of complex defects in head and neck","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e13479_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e13479_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e13479_bib14","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e13479_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/mc.23162","article-title":"Tumor immune microenvironment in head and neck cancers","volume":"59","author":"Chen","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.heliyon.2023.e13479_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00066","article-title":"Roles of PLODs in collagen synthesis and cancer progression","volume":"6","author":"Qi","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7150\/jca.35763","article-title":"Overexpressing PLOD family genes predict poor prognosis in gastric cancer","volume":"11","author":"Li","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2023.e13479_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3418398","article-title":"PLOD1 is a prognostic biomarker and mediator of proliferation and invasion in osteosarcoma","author":"Jiang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2023.e13479_bib20","article-title":"Identification of PLOD family genes as novel prognostic biomarkers for hepatocellular carcinoma","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189903","article-title":"A human pan-cancer system analysis of procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (Plod3)","volume":"22","author":"Gong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e13479_bib22","first-page":"42","article-title":"Procollagen-Lysine, 2-oxoglutarate 5-dioxygenase family: novel prognostic biomarkers and tumor microenvironment regulators for lower grade glioma","volume":"22","author":"Gong","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.heliyon.2023.e13479_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/genes13050787","article-title":"PLOD family: a novel biomarker for prognosis and personalized treatment in soft tissue sarcoma","volume":"13","author":"Gong","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.heliyon.2023.e13479_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3892\/ijo.2013.1808","article-title":"Identification of guanine nucleotide-binding protein \u03b3-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling","volume":"42","author":"Demokan","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib25","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1002\/hed.24072","article-title":"Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients","volume":"38","author":"Tomar","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.heliyon.2023.e13479_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/carcin\/bgs207","article-title":"Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma","volume":"33","author":"Pav\u00f3n","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.heliyon.2023.e13479_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0383-1","article-title":"Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab","volume":"6","author":"Capone","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.heliyon.2023.e13479_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2023.e13479_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2023.e13479_bib30","article-title":"PLOD2 is essential to functional activation of integrin \u03b21 for invasion\/metastasis in head and neck squamous cell carcinomas","volume":"23","author":"Ueki","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e13479_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1083\/jcb.152.3.545","article-title":"PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: implications for the pathology of Rieger syndrome","volume":"153","author":"Hjalt","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2021.08.002","article-title":"New mechanistic insights to PLOD1-mediated human vascular disease","volume":"239","author":"Koenig","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.heliyon.2023.e13479_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","article-title":"Epithelial-mesenchymal transition in tissue repair and fibrosis","volume":"365","author":"Stone","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.heliyon.2023.e13479_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121841","article-title":"Reversal of epithelial\u2013mesenchymal transition by natural anti-inflammatory and pro-resolving lipids","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2023.e13479_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: inseparable actors of cancer progression","volume":"11","author":"Suarez-Carmona","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e13479_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1359\/JBMR.040323","article-title":"Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells","volume":"19","author":"Pornprasertsuk","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.heliyon.2023.e13479_bib38","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.21037\/tcr-21-73","article-title":"Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer","volume":"10","author":"Qi","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.heliyon.2023.e13479_bib39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0022034518771923","article-title":"Emerging insights into wnt\/\u03b2-catenin signaling in head and neck cancer","volume":"97","author":"Alamoud","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.heliyon.2023.e13479_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.590912","article-title":"Roles of the Wnt signaling pathway in head and neck squamous cell carcinoma","volume":"7","author":"Xie","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2023.e13479_bib41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.31557\/APJCP.2019.20.4.995","article-title":"Wnt signaling: a potential therapeutic target in head and neck squamous cell carcinoma","volume":"20","author":"Javed","year":"2019","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.heliyon.2023.e13479_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00244","article-title":"Promising druggable target in head and neck squamous cell carcinoma: Wnt signaling","volume":"7","author":"Aminuddin","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e13479_bib44","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/cncr.28485","article-title":"No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period","volume":"120","author":"Wu","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.heliyon.2023.e13479_bib45","article-title":"ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma","author":"Zhou","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.heliyon.2023.e13479_bib46","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.2147\/CMAR.S223201","article-title":"Integrin \u03b15\/itga5 promotes the proliferation, migration, invasion and progression of oral squamous carcinoma by epithelial\u2013mesenchymal transition","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.heliyon.2023.e13479_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108435","article-title":"MiR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14","volume":"9","author":"Jia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e13479_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.oraloncology.2014.02.003","article-title":"GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity","volume":"50","author":"Lin","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-019-0369-5","article-title":"Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance","volume":"39","author":"Chang","year":"2019","journal-title":"Cancer Commun."},{"key":"10.1016\/j.heliyon.2023.e13479_bib50","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1128\/MCB.00737-14","article-title":"The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer","volume":"34","author":"Hollern","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib51","article-title":"High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma","volume":"34","author":"Li","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.heliyon.2023.e13479_bib52","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/dna.2019.5170","article-title":"Identification of potential diagnostic and prognostic values of P4HA1 expression in lung cancer, breast cancer, and head and neck cancer","volume":"39","author":"Li","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib54","article-title":"Tlr3 agonists improve the immunostimulatory potential of cetuximab against egfr+ head and neck cancer cells","volume":"2","author":"Lim","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.heliyon.2023.e13479_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105508","article-title":"Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma","volume":"122","author":"Ida","year":"2021","journal-title":"Oral Oncol."},{"key":"10.1016\/j.heliyon.2023.e13479_bib56","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jnci\/djz036","article-title":"STAT3 modulation of regulatory T cells in response to radiation therapy in head and neck cancer","volume":"111","author":"Oweida","year":"2019","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023006862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023006862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:59:56Z","timestamp":1776877196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023006862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2405844023006862"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13479","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e13479"}}